Product Information
DAPSONE 5% GEL is a generic product labeled by Mayne Pharma, priced at $0.6638 per GM under NDC 51862012360. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on Oct 13, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/g
Manufacturer
Mayne PharmaNDC
51862012360
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DAPSONEApproval Type
Generic (ANDA)
FDA Application
ANDA212383FDA Approved
10/13/2023
TE Code
AB
On Market Since
2/14/2024
Pharmacological Classes
Price Statistics
The NADAC for DAPSONE 5% GEL has been published 130 times since Apr 10, 2024, and over the history we have for it it has declined 66.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6638 per GM |
|---|---|
| All-time high | $1.9828 (Apr 10, 2024) |
| All-time low | $0.6638 (Sep 23, 2026) |
| 52-week high | $1.0392 |
| 52-week low | $0.6638 |
| Median price | $1.2871 |
| Average price | $1.2164 |
| Largest weekly change | -30.7% (Jul 17, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dapsone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DAPSONE 5% GEL?
The current National Average Drug Acquisition Cost (NADAC) for DAPSONE 5% GEL, manufactured by Mayne Pharma, is $0.6638 per GM (NDC 51862012360), effective Sep 30, 2026.
How has the price of DAPSONE 5% GEL changed over time?
Over the history we have for it, the NADAC for DAPSONE 5% GEL has declined 66.5%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for DAPSONE 5% GEL?
Since Apr 10, 2024, the NADAC for DAPSONE 5% GEL has ranged from a low of $0.6638 (Sep 23, 2026) to a high of $1.9828 (Apr 10, 2024), with a median of $1.2871 per GM.
Are there cheaper alternatives to DAPSONE 5% GEL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DAPSONE 5% GEL in a comparable dosage form, but none are currently priced below it.
Who manufactures DAPSONE 5% GEL?
DAPSONE 5% GEL (NDC 51862012360) is labeled by Mayne Pharma, and CMS classifies it as a generic product.